Tolerability and efficacy of carvedilol in patients with New York heart association class IV heart failure

Journal of the American College of Cardiology

Volumn 33, Issue 4, 1999, Pages 924-931

  Macdonald, Peter S ^a   Keogh, Anne M ^a   Aboyoun, Christina L ^a   Lund, Mayanna ^a   Amor, Raul ^a   McCaffrey, Dermot J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ACUTE KIDNEY FAILURE; ADULT; ANOREXIA; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL;

ACTUARIAL ANALYSIS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AUSTRALIA; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0033558688     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00680-9     Document Type: Article

References (29)

1. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36.
2. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979;i:1374-6.
3. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metroprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (see comments). Lancet 1993;342:1441-6.
4. Fisher ML, Gottlieb SS, Plotnick GD, et al. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial.) Am Coll Cardiol 1994;23:943-50.
5. Metra M, Nardi M, Giubbini R, Cas LD. Effects of short-and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1678-87.
6. Bristow M, Gilbert E, Abraham W, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996;94:690-7.
7. Doughty R, Whalley G, Gamble G, et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997;29:1060-6.
8. Olsen S, Gilbert E, Renlund D, Taylor D, Yanowitz F, Bristow M. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 1995;25:1225-31.
9. Krum H, Sackner-Bernstein J, Goldsmith R, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995;92:1499-506.
10. Packer M, Bristow M, Cohn J, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
11. Australia-New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997;349:375-80.
12. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 1997;18;560-5.
13. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997;30:27-34.
14. Colucci W, Packer M, Bristow M, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996;94:2800-6.
15. Sahn D, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-82.
16. Teichholz L, Kreulen T, Herman M, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence and absence of asynergy. Am J Cardiol 1976;37:7-11.
17. Sackner-Bernstein J, Krum H, Goldsmith R, et al. Should worsening heart failure early after initiation of beta-blocker therapy for chronic heart failure preclude long-term treatment (abstr). Circulation 1995;92 Suppl 1:I-395.
18. Dzau V, Colucci W, Hollenberg N, Williams G. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63:645-51.
19. Lee W, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
20. Parameshwar J, Keegan J, Sparrow J, Sutton G, Poole-Wilson P. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992;123:421-6.
21. Australia-New Zealand Heart Failure Research Collaborative Study. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischaemic heart disease. Circulation 1995;92:212-8.
22. Packer M, Colucci W, Cohn J, et al. Relationship between long-term changes in left ventricular function and clinical outcome in patients with chronic heart failure treated with carvedilol. J Am Coll Cardiol 1997;29:64A.
23. Eichhorn E. The paradox of beta-adrenergic blockade for the management of congestive heart failure. Am J Med 1992;92: 527-38.
24. Tesch P. Exercise performance and β-blockade. Sports Med 1985;2:389-412.
25. Franciosa J, Wilen M, Ziesche S, Cohn J. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
26. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Co-operative North Scandinavian Enalapril Survival Study. N Engl J Med 1987;316:1429-35.
27. Keogh A, Baron D, Hickie J. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-8.
28. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7.
29. Fisher M, Gottlieb S, Bennett S. Response to β-blocker in elderly patients with severe heart failure (abstract). J Am Coll Cardiol 1997;29:465A.